Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 6,966 | 6,997 | 8,716 | 5,719 | 5,425 |
| Cost of Goods | 3,381 | 3,188 | 3,729 | 2,832 | 2,803 |
| Gross Profit | 3,585 | 3,809 | 4,987 | 2,887 | 2,622 |
| Operating Expenses | 13,739 | 10,426 | 9,345 | 9,026 | 7,622 |
| Operating Income | -9,773 | -6,429 | -3,629 | -5,307 | -4,197 |
| Interest Expense | 355 | 353 | 306 | 298 | 300 |
| Other Income | -6,238 | 30 | 18 | 2 | 14 |
| Pre-tax Income | -16,366 | -6,752 | -3,917 | -5,603 | -4,483 |
| Net Income Continuous | -16,366 | -6,752 | -3,917 | -5,603 | -4,483 |
| Net Income | $-16,366 | $-6,752 | $-3,917 | $-5,603 | $-4,483 |
| EPS Basic Total Ops | -0.14 | -0.06 | -0.04 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.14 | -0.06 | -0.04 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.14 | -0.06 | -0.04 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.14 | -0.06 | -0.04 | -0.04 | -0.04 |
| EBITDA(a) | $-9,049 | $-5,778 | $-2,975 | $-4,844 | $-3,753 |